<DOC>
	<DOCNO>NCT00003778</DOCNO>
	<brief_summary>Phase II trial study effectiveness dolastatin 10 treat patient recurrent metastatic soft tissue sarcoma . Drugs use chemotherapy use different way stop tumor cell divide stop grow die .</brief_summary>
	<brief_title>Dolastatin 10 Treating Patients With Recurrent Metastatic Soft Tissue Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate patient recurrent metastatic soft tissue sarcoma treat dolastatin 10 . II . Determine toxicity regimen patient population . OUTLINE : This open label , multicenter study . Patients stratify accord center , prior therapy , histologic subtype , stage disease diagnosis , current status disease ( recurrent vs metastatic ) . Patients receive dolastatin 10 IV 10 minute . Treatment repeat every 21 day absence disease progression unacceptable toxicity . Patients follow 1 month .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Dolastatin 10</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven recurrent metastatic soft tissue sarcoma No rhabdomyosarcoma , Ewing 's sarcoma , chondrosarcoma , osteogenic sarcoma , mesothelioma , Kaposi 's sarcoma Bidimensionally measurable disease previously irradiate disease site ( ) even progression within radiation field Pulmonary nodule ( ) least 1 x 1 cm No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 0 1 Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Bilirubin great 1.5 mg/dL AST ALT less 1.5 time upper limit normal ( ULN ) ( 3 time ULN liver metastasis present ) Creatinine great 1.5 mg/dL Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 3 month study No uncontrolled infection No history prior malignancy within past 5 year except basal cell squamous cell skin cancer , carcinoma situ cervix , malignancy complete remission PRIOR CONCURRENT THERAPY : No 1 prior chemotherapy regimen adjuvant set No prior chemotherapy metastatic disease At least 4 week since prior chemotherapy ( 6 week mitomycin nitrosoureas ) At least 4 week since prior radiotherapy Recovered prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2000</verification_date>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>